{"id":17834,"date":"2024-10-30T08:36:29","date_gmt":"2024-10-30T08:36:29","guid":{"rendered":"https:\/\/imagenavanzada.es\/?page_id=17834"},"modified":"2026-11-03T13:09:28","modified_gmt":"2026-11-03T13:09:28","slug":"home","status":"publish","type":"page","link":"https:\/\/imagenavanzada.es\/en\/","title":{"rendered":"Home"},"content":{"rendered":"
\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Imaging for Screening, Prevention and Longevity<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

SEE EARLIER,<\/span>
CARE BETTER.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Featuring leading international speakers.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Event validated by Fenin<\/span><\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
UEMS\/SEAFORMEC accreditation has been requested.<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tRegister here<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
5 and 6 November 2026<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/i>
Auditorium, Hospital Universitario Ram\u00f3n y Cajal. Madrid<\/strong><\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Course directors:<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr. Antonio Luna<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Scientific Director, HT M\u00e9dica<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div>
\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr. Javier Bl\u00e1zquez<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Head of Radiology, Hospital Universitario Ram\u00f3n y Cajal<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div>
\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr. Ana Villanueva<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Abdominal and Pelvic CT Coordinator at HT M\u00e9dica<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Introduction<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

See earlier. Care better.<\/strong><\/p>\r\n

The 17th Advanced Medical Imaging Techniques Course \u2013 IMA 17 focuses on the growing role of medical imaging in screening, prevention, and longevity.<\/p>\r\n

Over two days, national and international experts will explore how advanced imaging, biomarkers, artificial intelligence, and new risk models are helping us detect earlier, stratify risk more accurately, and move towards more personalised medicine.<\/p>\r\n

A meeting designed to review the evidence, share experience, and discuss how to translate these advances into clinical practice.<\/p>\r\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t

Objectives <\/h2><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/i><\/span>\n\t\t\t<\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
    \r\n
  • Critically review the evidence, recommendations, benefits, potential harms and current controversies surrounding imaging-based screening in the general population and in risk-stratified groups.<\/li>\r\n
  • Examine state-of-the-art MRI, CT and spectral CT, ultrasound and multimodality strategies for cancer, cardiovascular, neurovascular and neurodegenerative screening and early disease detection.<\/li>\r\n
  • Understand how imaging can be integrated with clinical risk assessment, genomics, liquid biopsy (including circulating tumour cells and circulating tumour DNA and cell-free DNA), blood and urine biomarkers, artificial intelligence and quantitative\/opportunistic imaging biomarkers to enable precision prevention.<\/li>\r\n
  • Discuss practical implementation, including protocol optimisation, standardisation, actionable reporting, contrast use, management of incidental findings, follow-up pathways and health-system integration.<\/li>\r\n
  • Explore emerging directions in preventive imaging and longevity medicine, including subclinical disease detection, longitudinal risk assessment and imaging for selection and monitoring of preventive or disease-modifying therapies.<\/li>\r\n<\/ul>\r\n<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t
    \n\t\t\t\t\n\t\t\t\t\t

    Who is it for? <\/h2><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/i><\/span>\n\t\t\t<\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    IMA 17 is designed for professionals involved in screening, prevention, early detection, and precision medicine:<\/p>\r\n

      \r\n
    • Radiology:<\/strong> Radiologists and radiology residents.<\/li>\r\n
    • Clinical specialties:<\/strong> Oncology, cardiology, neurology, urology, gastroenterology, pulmonology, internal medicine, preventive medicine, genetics, primary care, and precision medicine.<\/li>\r\n
    • Imaging and healthcare technology:<\/strong> Imaging technologists, medical physicists, bioengineers, and biomedical engineers.<\/li>\r\n
    • Data and innovation:<\/strong> Data scientists, artificial intelligence specialists, and researchers.<\/li>\r\n
    • Other healthcare professionals:<\/strong> Professionals involved in the design, implementation, or evaluation of screening and prevention programmes.<\/li>\r\n<\/ul>\r\n<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t
      \n\t\t\t\t\n\t\t\t\t\t

      Programme <\/h2><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/i><\/span>\n\t\t\t<\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
      \n\t\t
      \n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t
      \r\n

      November 5, 2026<\/span> Precision Cancer Prevention, Organ-Specific Cancer Screening, Cardiovascular Prevention, Whole-Body MRI and Neuroimaging<\/span><\/h3>\r\n

      08:45 - 08:55h <\/span>OPENING<\/strong><\/span><\/h4>\r\n

      Chairs:<\/strong> Dr. Antonio Luna and Dr. Ana Villanueva<\/span><\/p>\r\n

        \r\n
      • 08:45 - 08:55h<\/strong><\/span> Welcome and Opening Remarks \u2014 Dr. Mar\u00eda Luisa Garc\u00eda Tom\u00e9<\/span> \u2014 Deputy Medical Director of Central Services at Ram\u00f3n y Cajal University Hospital.
        Dr. Miguel Chiva de Agust\u00edn<\/span> \u2014 Head of the Breast Radiology Section at Ram\u00f3n y Cajal University Hospital. Representing Dr. Javier Bl\u00e1zquez.
        Dr. Antonio Luna<\/span> \u2014 Scientific Director of HT M\u00e9dica and co-director of IMA 17.
        Dr. Ana Mar\u00eda Villanueva Campos<\/span> \u2014 Coordinator of Abdominal and Pelvic CT at HT M\u00e9dica and co-director of IMA 17.<\/em><\/li>\r\n<\/ul>\r\n

        08:55 - 09:45h <\/span>PRECISION CANCER PREVENTION<\/strong><\/span><\/h4>\r\n

        Chair:<\/strong> Dr. Antonio Luna<\/span><\/p>\r\n

          \r\n
        • 08:55 - 09:20h<\/strong><\/span> The Role of Imaging in Longevity and Precision Prevention \u2014 Where imaging fits alongside clinical risk assessment, laboratory biomarkers, genomics, functional testing and other screening tools; moving from detection to actionable prevention \u2014 Dr. \u00c1ngel Dur\u00e1ntez<\/span> \u2014 Cl\u00ednica Neleva, Spain<\/em><\/li>\r\n
        • 09:20 - 09:45h<\/strong><\/span> Beyond Imaging: Circulating Tumor Cells, Liquid Biopsy and Emerging Biomarkers for Cancer Screening and Interception \u2014 CTCs, circulating tumour DNA, cell-free DNA, epigenetic and molecular biomarkers, and their potential integration with imaging for early cancer detection and risk-adapted screening \u2014 Dr. Mar\u00eda Jos\u00e9 Serrano<\/span> \u2014 Liquid Biopsy and Cancer Interception Group, GENYO, Granada, Spain<\/em><\/li>\r\n<\/ul>\r\n

          09:45 - 10:40h <\/span>BREAST CANCER SCREENING \u2014 IMAGING + PRECISION RISK<\/strong><\/span><\/h4>\r\n

          Chair:<\/strong> Dr. Miguel Chiva \u00b7 Hospital Universitario Ram\u00f3n y Cajal<\/span><\/p>\r\n

            \r\n
          • 09:45 - 10:10h<\/strong><\/span> Breast Cancer Screening: From Population-Based Mammography to Risk-Adapted Imaging \u2014 Breast density, individualised risk, MRI, abbreviated MRI and current controversies \u2014 Dr. Ana Rodr\u00edguez<\/span> \u2014 HT M\u00e9dica\u2013Instituts Guirado, Barcelona; Breast Imaging Coordinator, HT M\u00e9dica<\/em><\/li>\r\n
          • 10:10 - 10:35h<\/strong><\/span> Beyond Imaging in Breast Cancer Risk Assessment and Screening: Genetics, Polygenic Risk and Emerging Blood Biomarkers \u2014 Integrating family history, germline genetics, polygenic risk, clinical factors and emerging circulating biomarkers into individualised screening and prevention strategies \u2014 Dr. Mar\u00eda Alejandra Rezqallah Ar\u00f3n<\/span> \u2014 Centro M\u00e9dico Teknon \/ Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain<\/em><\/li>\r\n
          • 10:35 - 10:40h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n

            10:40 - 11:10h <\/span>Coffee Break<\/strong><\/span><\/h4>\r\n

            11:10 - 12:05h <\/span>OTHER CANCER SCREENING<\/strong><\/span><\/h4>\r\n

            Chair:<\/strong> Dr. Ana Villanueva<\/span><\/p>\r\n

              \r\n
            • 11:10 - 11:35h<\/strong><\/span> Colorectal Cancer Screening: Where Does Imaging Fit? \u2014 Current strategies, CT colonography, indications, limitations and controversies \u2014 Dr. Stuart A. Taylor<\/span> \u2014 University College London, UK<\/em><\/li>\r\n
            • 11:35 - 12:00h<\/strong><\/span> Lung Cancer Screening with Low-Dose CT: Evidence, Risk-Based Selection and Emerging Imaging Biomarkers \u2014 Implementation, nodule management and future perspectives \u2014 Dr. Luis Gorospe<\/span> \u2014 Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain<\/em><\/li>\r\n
            • 12:00 - 12:05h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n

              12:05 - 13:40h <\/span>CARDIOVASCULAR SCREENING AND PRECISION PREVENTION<\/strong><\/span><\/h4>\r\n

              Chair:<\/strong> Dr. Jordi Broncano<\/span><\/p>\r\n

                \r\n
              • 12:05 - 12:30h<\/strong><\/span> Cardiac Imaging for Screening and Prevention: Who Should We Image and With Which Technique? \u2014 Echocardiography, coronary calcium, coronary CT angiography, cardiac MRI, vascular assessment and emerging CT\/PCCT applications \u2014 Dr. Jos\u00e9 Luis Zamorano<\/span> \u2014 Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain<\/em><\/li>\r\n
              • 12:30 - 12:55h<\/strong><\/span> Bridging Prospective Imaging Cohorts and Cardiovascular Prevention: Lessons from PESA, BioImage and REACT \u2014 Natural history of subclinical atherosclerosis, multiterritorial vascular imaging, risk reclassification and implications for precision prevention. \u2014 Dr. In\u00e9s Garc\u00eda-Lunar<\/span> \u2014 Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain<\/em><\/li>\r\n
              • 12:55 - 13:20h<\/strong><\/span> Coronary CT Angiography and CT-Derived FFR in Cardiovascular Screening: From Anatomic Detection to Functional Risk Stratification \u2014 Role of CCTA in detecting subclinical coronary atherosclerosis and the added value of CTA Plus \/ FFR-CT for functional assessment and risk-adapted management \u2014 Dr. Gorka Bastarrika<\/span> \u2014 Cl\u00ednica Universidad de Navarra, Pamplona, Spain<\/em><\/li>\r\n
              • 13:20 - 13:35h<\/strong><\/span> What is MyoStrain and what is its clinical utility as a screening technique: our experience \u2014 Dr. \u00c1lvaro Arribas Marcos<\/span> \u2014 Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain<\/em><\/li>\r\n
              • 13:35 - 13:40h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n

                13:40 - 14:40h <\/span>Lunch<\/strong><\/span><\/h4>\r\n

                14:40 - 16:00h <\/span>WHOLE-BODY MRI SCREENING<\/strong><\/span><\/h4>\r\n

                Chair:<\/strong> Dr. Antonio Luna<\/span><\/p>\r\n

                  \r\n
                • 14:40 - 15:05h<\/strong><\/span> Whole-Body MRI for Oncologic Screening: From High-Risk Populations to the Asymptomatic General Population \u2014 Evidence, indications, diagnostic performance, limitations and controversies \u2014 Dr. Antonio Luna<\/span> \u2014 Scientific Director, HT M\u00e9dica, Spain<\/em><\/li>\r\n
                • 15:05 - 15:30h<\/strong><\/span> Optimising and Standardising Whole-Body MRI for Screening: Acquisition, DWI, ONCO-RADS and Reporting \u2014 Protocol design, diffusion-weighted imaging, reproducibility, acquisition time and standardisation of interpretation and reporting \u2014 Dr. Kai Vilanova<\/span> \u2014 Cl\u00ednica Girona, Girona, Spain<\/em><\/li>\r\n
                • 15:30 - 15:55h<\/strong><\/span> The Story After the Scan: Lessons from Whole-Body MRI Screening at Scale \u2014 Dr. Todd Berry<\/span> \u2014 Prenuvo Medical Group. Virtual participation.<\/em><\/li>\r\n
                • 15:55 - 16:00h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n

                  16:00 - 16:25h <\/span>Industry Session<\/strong><\/span><\/h4>\r\n
                    \r\n
                  • 16:00 - 16:25h<\/strong><\/span> MRI for screening and preventive imaging: faster, quantitative and reproducible scans \u2014 Dr. Javier S\u00e1nchez-Gonz\u00e1lez<\/span> \u2014 Clinical Scientist at Philips Spain<\/em><\/li>\r\n<\/ul>\r\n

                    16:25 - 16:45h <\/span>Coffee Break<\/strong><\/span><\/h4>\r\n

                    16:45 - 19:00h <\/span>NEUROIMAGING \u2014 POPULATION SCREENING, PREVENTION, NEURODEGENERATION AND EPILEPSY<\/strong><\/span><\/h4>\r\n

                    Chair:<\/strong> Dr. Daniel Lourido \u00b7 Hospital Universitario Ram\u00f3n y Cajal<\/span><\/p>\r\n

                      \r\n
                    • 16:45 - 17:10h<\/strong><\/span> Dementia prediction using a large dataset of brain imaging linked to health data from the National Health Services (NHS) in Scotland \u2014 Dr. Mar\u00eda Vald\u00e9s Hern\u00e1ndez<\/span> \u2014 University of Edinburgh \/ Edinburgh Imaging, Edinburgh, UK. Virtual participation.<\/em><\/li>\r\n
                    • 17:10 - 17:35h<\/strong><\/span> The Role of Imaging in Neurovascular Prevention \u2014 Detection of silent cerebrovascular disease, vascular brain injury and small-vessel disease, and integration of cardiovascular and brain imaging for prevention \u2014 Dr. Marta Cort\u00e9s-Canteli<\/span> \u2014 Centro Nacional de Investigaciones Cardiovasculares (CNIC) \/ Centro de Neurociencias Cajal (CNC-CSIC), Madrid, Spain<\/em><\/li>\r\n
                    • 17:35 - 18:00h<\/strong><\/span> Imaging and Multimodal Biomarkers in Preclinical and Early Alzheimer\u2019s Disease \u2014 Neuroimaging, genetics and fluid biomarkers for early detection, risk stratification and definition of therapeutic windows \u2014 Dr. Teresa Cabada Giad\u00e1s<\/span> \u2014 Head of Neuroradiology Section, Hospital Universitario de Navarra (HUN), Pamplona, Spain<\/em><\/li>\r\n
                    • 18:00 - 18:25h<\/strong><\/span> Disease-Modifying Therapies in Alzheimer\u2019s Disease: Patient Selection, Biomarkers and Imaging Follow-up \u2014 Anti-amyloid therapies, biomarker-based eligibility, ARIA risk, MRI monitoring and multidisciplinary follow-up \u2014 Dr. V\u00edctor Antonio Blanco Palmero<\/span> \u2014 Memory Unit, Hospital Ruber Internacional; Memory Unit, Hospital Universitario 12 de Octubre, Madrid, Spain<\/em><\/li>\r\n
                    • 18:25 - 18:50h<\/strong><\/span> MRI in Epilepsy: From Structural Imaging to Advanced Phenotyping \u2014 Optimised MRI protocols, subtle epileptogenic lesions and advanced imaging approaches \u2014 Dr. Juan \u00c1lvarez-Linera<\/span> \u2014 Neuroradiologist specialising in epilepsy \u00b7 HT M\u00e9dica, Madrid, Spain<\/em><\/li>\r\n
                    • 18:50 - 19:00h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n<\/div><\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t\t
                      \r\n

                      November 6, 2026<\/span> Opportunistic Screening, Body Composition, Advanced Imaging and Prostate Cancer Screening<\/span><\/h3>\r\n

                      Special Session: Opportunistic Screening, Body Composition and Advanced Imaging<\/em><\/p>\r\n

                      08:45 - 11:45h <\/span>OPPORTUNISTIC SCREENING, BODY COMPOSITION AND ADVANCED IMAGING<\/strong><\/span><\/h4>\r\n

                      Chair:<\/strong> Dr. Beatriz Alvarez Sierra<\/span><\/p>\r\n

                        \r\n
                      • 08:45 - 09:10h<\/strong><\/span> Untapped Potential: Adding Value Through Image-Based Opportunistic Screening \u2014 Dr. Matthew Lee<\/span> \u2014 University of Wisconsin\u2013Madison, USA<\/em><\/li>\r\n
                      • 09:10 - 09:35h<\/strong><\/span> Spectral CT for Prevention: One Scan, More Answers. \u2014 Dr. Nicol\u00e1s Almeida<\/span> \u2014 Hospital Universitario Nuestra Se\u00f1ora del Rosario, Madrid, Spain<\/em><\/li>\r\n
                      • 09:35 - 10:00h<\/strong><\/span> Opportunistic CT Biomarkers of Cardiometabolic Health: Fat, Calcification, and Beyond \u2014 Dr. Matthew Lee<\/span> \u2014 University of Wisconsin\u2013Madison, USA<\/em><\/li>\r\n
                      • 10:00 - 10:25h<\/strong><\/span> Management of Incidental Findings in Imaging-Based Screening \u2014 Classification, communication, follow-up strategies, risk-adapted management and minimising unnecessary diagnostic cascades \u2014 Dr. Ana Villanueva<\/span> \u2014 Body CT Coordinator, HT M\u00e9dica, Madrid, Spain<\/em><\/li>\r\n
                      • 10:25 - 10:50h<\/strong><\/span> Beyond Traditional Risk Assessment: CT Biomarkers of Aging, Longevity, and Explainable AI-Driven Prediction \u2014 Dr. Matthew Lee<\/span> \u2014 University of Wisconsin\u2013Madison, USA<\/em><\/li>\r\n
                      • 10:50 - 11:15h<\/strong><\/span> Whole-Body MRI in Children with Tumour Predisposition \u2014 Dr. Emilio J. Inarejos Clemente<\/span> \u2014 Hospital Sant Joan de D\u00e9u, Barcelona, Spain<\/em><\/li>\r\n
                      • 11:15 - 11:30h<\/strong><\/span> AI applied to routine imaging: assessment of osteoporosis, abdominal volumetry and breast arterial calcification \u2014 Dr. Patrick Kara-Schmidt<\/span> \u2014 Floy, Germany<\/em><\/li>\r\n
                      • 11:30 - 11:45h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n

                        11:45 - 12:15h <\/span>Coffee Break<\/strong><\/span><\/h4>\r\n

                        12:15 - 13:45h <\/span>PROSTATE CANCER SCREENING \u2014 MRI + MULTIMODAL RISK<\/strong><\/span><\/h4>\r\n

                        Chair:<\/strong> Dr. Ernesto Castillo<\/span><\/p>\r\n

                          \r\n
                        • 12:15 - 12:40h<\/strong><\/span> Prostate MRI as a Screening Tool: PRISM Recommendations and the Emerging \u201cMRI-first\u201d Paradigm \u2014 Risk-adapted screening and the role of MRI in modern diagnostic pathways \u2014 Dr. Sadhna Verma<\/span> \u2014 University of Cincinnati, USA<\/em><\/li>\r\n
                        • 12:40 - 13:05h<\/strong><\/span> Beyond MRI: The Future of Risk-Adapted Prostate Cancer Screening \u2014 PSA-based strategies, serum and urine biomarkers, germline and polygenic risk, risk calculators and integration with MRI in population screening programmes \u2014 Dr. Juan Ignacio Mart\u00ednez-Salamanca<\/span> \u2014 LYX Urolog\u00eda, Madrid, Spain<\/em><\/li>\r\n
                        • 13:05 - 13:30h<\/strong><\/span> PI-RADS 2027: The New Version \u2014 What\u2019s Changing and Implications for Screening and Diagnosis \u2014 Dr. Sadhna Verma<\/span> \u2014 University of Cincinnati, USA<\/em><\/li>\r\n
                        • 13:30 - 13:45h<\/strong><\/span> Block Q&A and Discussion \u2014 All Faculty<\/span><\/em><\/li>\r\n<\/ul>\r\n

                          13:45 - 14:00h <\/span>Industry Session<\/strong><\/span><\/h4>\r\n
                            \r\n
                          • 13:45 - 14:00h<\/strong><\/span> The role of AI in prostate cancer screening and diagnosis \u2014 Dr. David Bazaga<\/span> \u2014 VP of Product, Quibim<\/em><\/li>\r\n<\/ul>\r\n

                            14:00 - 14:15h <\/span>Closing<\/strong><\/span><\/h4>\r\n

                            Chairs:<\/strong> Dr. Antonio Luna and Dr. Ana Villanueva<\/span><\/p>\r\n

                              \r\n
                            • 14:00 - 14:15h<\/strong><\/span> Closing Remarks \u2014 Course Directors<\/span><\/em><\/li>\r\n<\/ul>\r\n<\/div><\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t
                              \n\t\t\t\t\n\t\t\t\t\t

                              Location <\/h2><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/i><\/span>\n\t\t\t<\/i><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
                              \n\t\t
                              \n\t\t\t\t
                              \n\t\t\t\t
                              \n\t\t\t\t\t